Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). C21 Investments's share price for the quarter that ended in Mar. 2026 was $0.271. C21 Investments's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 117.84 Mil. Therefore, C21 Investments's market cap for the quarter that ended in Mar. 2026 was $31.93 Mil.
C21 Investments's quarterly market cap
increased
from Sep. 2025 ($43.75 Mil) to Dec. 2025 ($45.47 Mil) but then
declined
from Dec. 2025 ($45.47 Mil) to Mar. 2026 ($31.93 Mil).
C21 Investments's annual market cap
declined
from Jan. 2024 ($48.02 Mil) to Mar. 2025 ($21.83 Mil) but then
increased
from Mar. 2025 ($21.83 Mil) to Mar. 2026 ($31.93 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. C21 Investments's Enterprise Value for Today is $39.28 Mil.
C21 Investments (OTCPK:CXXIF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
C21 Investments Market Cap Related Terms
C21 Investments Market Cap Historical Data
* Premium members only.
The historical data trend for C21 Investments's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
C21 Investments Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, C21 Investments's Market Cap distribution charts can be found below:
* The bar in red indicates where C21 Investments's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
C21 Investments's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
C21 Investments (CXXIF) has a Market Cap of $28.42 Mil as of Jul. 03, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on C21 Investments and its competitors. According to the industry distribution chart, C21 Investments ranks #766 out of 1024 companies in the Drug Manufacturers industry, placing it in the top 74.8%.
Is C21 Investments' Market Cap too high?
C21 Investments' current Market Cap is $28.42 Mil. The Drug Manufacturers industry median Market Cap is 212.74. C21 Investments' value of $28.42 Mil is 86.6% below this industry median. Based on the distribution chart, C21 Investments ranks #766 out of 1024 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, C21 Investments has a GF Score™ of 31/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does C21 Investments' Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, C21 Investments ranks #766 out of 1024 companies for Market Cap. This places C21 Investments in the lower half of its industry. The industry median Market Cap is 212.74. C21 Investments' value of $28.42 Mil is 86.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 212.74, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. C21 Investments's current Market Cap of $28.42 Mil is 86.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on C21 Investments and its competitors. For the Drug Manufacturers industry, the median Market Cap is 212.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. C21 Investments's current Market Cap is $28.42 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is C21 Investments stock overvalued right now?
Based on GuruFocus' analysis, C21 Investments (CXXIF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.28, compared to a current price of $0.24 — trading 13% below its estimated fair value. The current Market Cap is $28.42 Mil and 86.6% below the Drug Manufacturers industry median of 212.74. C21 Investments' overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For C21 Investments (CXXIF), the current Market Cap is $28.42 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is C21 Investments (CXXIF) Overvalued in 2026?
Based on GuruFocus' analysis, C21 Investments stock appears to be undervalued.
The current stock price of $0.24 is trading 13% below its estimated GF Value™ of $0.28.
GuruFocus considers C21 Investments to be Modestly Undervalued.
Key valuation signals for CXXIF:
Market Cap: $28.42 Mil
GF Value™: $0.28 vs. price of $0.24 (13% below fair value)
Industry Position: 86.6% below the Drug Manufacturers median (#766 of 1024)
No single metric tells the full story. See the CXXIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
C21 Investments Inc is a vertically integrated cannabis company that cultivates, processes, distributes, and sells quality cannabis and hemp-derived consumer products in Nevada, U.S.A., and the United States. The Company is focused on value creation through the disciplined acquisition and integration of core retail, manufacturing, and distribution assets in strategic markets, leveraging industry retail revenues with high-growth potential and multi-market branded consumer packaged goods (CPG). The Company focuses on scalable opportunities in key markets through retail operational excellence, expanding its retail footprint through value-add acquisitions in existing markets, and branded CPG expansion through captive retail and wholesale channels.
31GF Score
Get the complete analysis for CXXIF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CXXIF has been successfully added to your 
